Current Concepts in the Management of Malignant Hyperthermia
by Tae W. Kim, MD, Henry Rosenberg, MD and Nina Nami, MD
Malignant hyperthermia (MH) is a pharmacogenetic disorder triggered by
exposure to halogenated volatile anesthetic gases and succinylcholine.
The underlying mechanism for this potentially lethal condition involves
the unregulated release of calcium from the sarcoplasmic reticulum into